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Background
ODIN was a Phase IIIb, randomised, open-label trial
showing non-inferiority of DRV/r 800/100mg qd vs 600/
100mg bid (+ ≥2 NRTIs) in treatment-experienced HIV-
1-infected adults with no DRV resistance-associated
mutations at screening. We evaluated the effect of demo-
graphic and baseline (BL) disease parameters on virologi-
cal response (VR) of qd vs bid DRV/r at Week 48.
Methods
Week 48 VR (HIV-1 RNA <50 copies/mL; ITT-TLOVR)
was analysed by subgroups including gender, age, race,
HIV clade, BL HIV-1 RNA and CD4 count.
Results
Week 48 VR was 72.1% for DRV/r qd vs 70.9% for bid
(95% CI = -6.1 to 8.5%). Week 48 VR by gender, age, race,
HIV clade, BL CD4 count and HIV-1 RNA is reported
(Table 1).
Conclusions
VR was comparable with DRV/r qd and bid regardless
of subgroup analysed. As the trial was not powered for
treatment comparisons in subgroups, and as numbers
were small for some subgroups, these exploratory find-
ings should be interpreted with caution.
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Table 1 % patients with HIV-1 RNA <50 copies/mL at
Week 48
DRV/r
qd
DRV/r
bid
Baseline factor N%
response
N%
response
Difference in
response (95% CI)
HIV-1 RNA (as
stratified)
(copies/mL)
≤50,000 222 78.4 224 76.8 1.6 (-6.2, 9.4)
>50,000 72 52.8 72 52.8 0.0 (-16.4, 16.4)
CD4 count
(cells/mm
3)
<50 13 53.8 3 100 -46.2 (-109.6, 17.3)
50-<100 36 58.3 35 57.1 1.2 (-22.2, 24.6)
100-<200 76 77.6 77 67.5 10.1 (-4.1, 24.3)
200-<350 108 72.2 107 74.8 -2.5 (-14.4, 9.3)
≥350 61 77.0 74 74.3 2.7 (-12.0, 17.4)
Gender
Female 115 69.6 98 69.4 0.2 (-12.3, 12.7)
Male 179 73.7 198 71.7 2.0 (-7.0, 11.1)
Age (years)
≤30 35 71.4 35 60.0 11.4 (-11.0, 33.9)
30-≤45 180 75.6 169 72.8 2.8 (-6.4, 12)
45-≤55 64 60.9 72 72.2 -11.3 (-27.2, 4.6)
55-≤65 14 78.6 18 66.7 11.9 (-20.6, 44.4)
>65 1 100 2 100 0 (0, 0)
Race
Black 83 62.7 72 65.3 -2.6 (-17.9, 12.7)
Caucasian 102 71.6 110 69.1 2.5 (-9.9, 14.9)
Hispanic 47 72.3 59 67.8 4.5 (-13.2, 22.3)
Asian 48 89.6 41 87.8 1.8 (-11.6, 15.1)
Other 14 71.4 14 78.6 -7.1 (-40.7, 26.4)
Clade
B 179 70.4 199 64.3 6.4 (-3.4, 15.6)
Non-B 115 74.8 97 84.5 -9.8 (-20.7,1.2)
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